MedTech Strategist's complimentary Community Blog focuses on the people and the passions that drive the global medical device industry. Sign up for our e-Newsletter to receive new articles and video interviews directly to your inbox.
e-Newsletter Browse
With full commercial launch of its automated insulin delivery system expected by year’s end, Sequel’s VP of marketing provides details on the company’s competitive strategy and its future plans. Excerpted from our recent Q&A with Chris Gilbert.
CMS wants to add ADHD to its list of reimbursed digital therapeutics. Excerpted from Pathways’ Picks July 16: CDRH Separations, Medicare Rules, Global Guidelines, and More.
The Trump administration delays ethylene oxide emission compliance for device companies. Excerpted from Pathways’ Picks July 23: Trump’s AI Plan, Global Reliance, Africa, Asia, and EU Updates.
CMS wants to add ADHD to its list of reimbursed digital therapeutics. Excerpted from Pathways’ Picks July 16: CDRH Separations, Medicare Rules, Global Guidelines, and More.